SIMEONE, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 19.274
EU - Europa 14.024
AS - Asia 9.093
SA - Sud America 557
AF - Africa 43
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 34
Totale 43.066
Nazione #
US - Stati Uniti d'America 19.149
UA - Ucraina 3.512
CN - Cina 3.234
PL - Polonia 2.560
SG - Singapore 2.520
IT - Italia 2.395
HK - Hong Kong 1.977
DE - Germania 1.952
FI - Finlandia 921
FR - Francia 723
RU - Federazione Russa 626
TR - Turchia 601
IE - Irlanda 575
BR - Brasile 510
GB - Regno Unito 392
IN - India 265
VN - Vietnam 218
SE - Svezia 97
CA - Canada 94
BE - Belgio 77
IR - Iran 64
ID - Indonesia 60
NL - Olanda 43
AU - Australia 37
EU - Europa 34
AT - Austria 32
JP - Giappone 23
CZ - Repubblica Ceca 20
AR - Argentina 19
MX - Messico 19
ES - Italia 17
AZ - Azerbaigian 10
EG - Egitto 10
MY - Malesia 10
BD - Bangladesh 9
MU - Mauritius 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
KG - Kirghizistan 8
RO - Romania 8
SA - Arabia Saudita 8
CH - Svizzera 7
NO - Norvegia 7
PT - Portogallo 7
EC - Ecuador 6
EE - Estonia 6
IQ - Iraq 6
JM - Giamaica 6
KR - Corea 6
LV - Lettonia 6
MA - Marocco 6
BO - Bolivia 5
DZ - Algeria 5
LA - Repubblica Popolare Democratica del Laos 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AL - Albania 4
CO - Colombia 4
KH - Cambogia 4
KZ - Kazakistan 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
VE - Venezuela 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
NG - Nigeria 3
PA - Panama 3
PE - Perù 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
HU - Ungheria 2
IS - Islanda 2
JO - Giordania 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
TM - Turkmenistan 2
BH - Bahrain 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
KW - Kuwait 1
MK - Macedonia 1
SI - Slovenia 1
SM - San Marino 1
Totale 43.062
Città #
Fairfield 2.582
Warsaw 2.553
Jacksonville 2.466
Hong Kong 1.974
Woodbridge 1.736
Singapore 1.682
Ashburn 1.600
Princeton 1.115
Cambridge 1.054
Houston 1.031
Seattle 1.013
Wilmington 980
Ann Arbor 899
Nanjing 729
Chandler 619
Beijing 576
Dublin 573
Helsinki 531
Istanbul 503
New York 370
Nanchang 307
Dearborn 250
Des Moines 246
Moscow 219
Shenyang 201
Dong Ket 196
Milan 179
Changsha 177
San Diego 159
Hebei 152
Jinan 133
Shanghai 131
Tianjin 131
Brescia 126
Rome 116
Jiaxing 108
Los Angeles 108
The Dalles 103
Kunming 90
Verona 75
Brussels 71
Kocaeli 69
Toronto 69
Boardman 58
Munich 58
Washington 58
Jakarta 57
Nürnberg 57
Hangzhou 56
Zhengzhou 56
San Mateo 55
Ardabil 53
Falkenstein 51
London 49
São Paulo 48
Monmouth Junction 47
San Francisco 47
Lanzhou 43
Norwalk 43
Augusta 41
Frankfurt am Main 39
Ningbo 39
Guangzhou 37
Düsseldorf 33
Leawood 31
Haikou 29
Lancaster 29
Bologna 28
Hefei 25
Turin 25
Taizhou 24
Turku 24
Changchun 23
Redwood City 23
Rio de Janeiro 22
Bari 21
Santa Clara 20
Fuzhou 19
Nuremberg 19
Taiyuan 19
Pune 18
Belo Horizonte 17
Napoli 17
Orange 17
Phoenix 16
Vienna 16
Newark 15
Kilburn 14
Lauterbourg 14
Naples 14
Padova 14
Canberra 13
Dallas 13
Brno 12
Brooklyn 12
Florence 12
Modena 12
Hanover 11
Melbourne 11
Parma 11
Totale 29.687
Nome #
Reflusso vescico ureterale nel rene trapiantato 340
INCONTINENZA URINARIA NELL'ANZIANO da Linee guida sull'incontinenza 4° Consultazione internazionale sull'incontinenza- Raccomandazioni ICI 2009 (traduzione in lingua italiana) 314
Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction 266
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 263
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 256
Complex Relationships between Occupation, Environment, DNA Adducts, Genetic Polymorphisms and Bladder Cancer in a Case-Control Study Using a Structural Equation Modeling. 255
CALCOLOSI MOLLE CALICEALE: UN CASO DI DIFFICILE DIAGNOSI 252
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 250
REIMPIANTO URETERALE LAPAROSCOPICO ROBOT-ASSISTED PER REFLUSSO VESCICO URETERALE RECIDIVO A INFILTRAZIONE CON MACROPLASTIQUE 244
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 210
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma 197
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 195
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 184
Caratterizzazione dei linfonodi retroperitoneali in risonanza magnetica con mezzo di contrasto linfonodo specifico (AMI227): confronto con l'istologia 183
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 182
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 176
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 176
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 174
Pros-IT CNR: an Italian prostate cancer monitoring project 168
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 163
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 162
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 160
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 155
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 155
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 152
Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses 152
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 150
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 149
18F-FDG PET/CT in a Patient Affected by Renal Collecting Duct (Bellini) Carcinoma 148
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 147
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 146
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 144
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 141
The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy 140
TERAPIA ENDOCAVITARIA DI SECONDA LINEA CON GEMCITABINA NELLA NEOPLASIA VESCICALE NON MUSCOLO INVASIVA RECIDIVA AD ALTO RISCHIO 139
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 139
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study. 137
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 137
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset 137
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 136
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 136
Approccio anatomo-clinico alla patologia della prostata 135
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 135
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 135
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 134
[High-intensity focused ultrasound (HIFU): our experience in the treatment of prostate cancer relapsing after radiotherapy]. 133
Serum vitamin D and prostate cancer prognosis: The story continues 133
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 133
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 133
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 133
Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial 133
Prediction tools in non-muscle invasive bladder cancer 132
Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma 131
Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases 131
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 130
[Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor]. 130
DRENAGGIO PERCUTANEO TRANSPERINEALE ECOGUIDATO DEGLI ASCESSI PROSTATICI Transperitoneal percutaneous echo-guided drainage of prostatic abscesses 130
TRATTAMENTO CON EMBOLIZZAZIONE SUPERSELETTIVA DEL PRIAPISMO AD ALTO FLUSSO DA FISTOLA ARTERO-CAVERNOSA 130
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 130
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 130
External histopathological validation of the surface-intermediate-base margin score 130
[Sliding-clip robotic nephropexy]. 129
[Insignificant prostate cancer: charateristics and predictive factors]. 129
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 128
Reply by Authors 128
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 127
Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project) 127
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed? 126
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function 125
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 125
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 125
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 124
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 124
LA DIFFERENZIAZIONE SARCOMATOIDE INFLUENZA NEGATIVAMENTE LA PROGNOSI NEI PAZIENTI AFFETTI DA CARCINOMA A CELLULE RENALI INDIPENDENTEMENTE DALL'ISTOTIPO 123
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 123
PROSPECTIVE ANALYSIS OF COMPLICATIONS AND THEIR PREDICTIVE FACTORS AFTER PARTIAL NEPHRECTOMY IN A MULTICENTER COMPARATIVE ITALIAN STUDY (RECORD1) 123
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 123
L'INIEZIONE PERIOSTIALE DI TEFLON NEL TRATTAMENTO DEL REFLUSSO VESCICO-URETERALE DELL'ADULTO. RISULTATI A DISTANZA 122
The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm(3)): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease 122
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 122
The occurrence of intraoperative complications during partial nephrectomy and their impact on postoperative outcome: results from the RECORd1 project 121
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 121
Riparazione di fistola vescico-rettale secondo la tecnica di york mason 120
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 120
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 120
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 119
VENOUS TUMOR THROMBUS CONSISTENCY IS NOT PREDICTIVE OF SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA: A RETROSPECTIVE STUDY ON 147 PATIENTS 119
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 119
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 118
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 118
Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis 118
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 118
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 117
Nerve growth factor signaling in prostate health and disease. 117
The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease. 116
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 116
[Did the staging of renal neoplasm improve with time? Retrospective study on a cohort of 2000 patients]. 115
[Intrinsic ureteral endometriosis: description of a striking instance.] 115
NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS 114
Histological variants in non-muscle invasive bladder cancer 114
Totale 14.881
Categoria #
all - tutte 225.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 225.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.400 0 0 0 0 0 0 0 0 0 0 616 784
2020/20219.080 289 838 504 1.086 433 1.071 377 1.136 1.070 964 860 452
2021/20224.045 293 789 78 243 70 169 134 315 223 522 312 897
2022/20232.664 600 58 77 102 178 804 20 205 299 36 147 138
2023/20243.980 185 71 243 412 186 666 137 127 1.137 89 64 663
2024/20256.567 81 55 29 1.182 912 759 821 233 880 650 965 0
Totale 43.823